Industry / Germany
Boehringer Ingelheim Finally Increases Presence
July 2008 | Company News AlertIndia is one the leading emerging markets for pharmaceutical companies. Sales of medicines are experiencing double digit growth each year, low labour costs makes it a premier manufacturing hub, and the vast treatment-naïve population makes it an attractive location for clinical trials. Accordingly, it would be safe to presuppose that every multinational drugmaker has a sizeable presence on the sub-continent? The answer is a surprising no and German firm Boehringer Ingelheim is one of them. BMI takes a look at the tactics being employed by the Rhineland-Palatinate company to penetrate the Indian
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
